CELL FORGE 1 Trademark

Trademark Overview

On Thursday, April 22, 2021, a trademark application was filed for CELL FORGE 1 with the United States Patent and Trademark Office. The USPTO has given the CELL FORGE 1 trademark a serial number of 90663491. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, September 13, 2023. This trademark is owned by Allogene Therapeutics, Inc.. The CELL FORGE 1 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
cell forge 1

General Information

Serial Number90663491
Word MarkCELL FORGE 1
Filing DateThursday, April 22, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, September 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 1, 2022

Trademark Statements

Description of MarkThe mark consists of the number 1 written in red within a circle made of red and green polka dots which overlaps a red circle containing the words "Cell Forge" written in green.
Goods and ServicesPharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Pseudo MarkCELL FORGE ONE
Indication of Colors claimedThe color(s) red and green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"CELL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023SOU EXTENSION 3 GRANTED
Wednesday, September 13, 2023SOU EXTENSION 3 FILED
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Saturday, January 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU EXTENSION 2 GRANTED
Thursday, January 19, 2023SOU EXTENSION 2 FILED
Thursday, January 19, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2022SOU EXTENSION 1 GRANTED
Monday, September 12, 2022SOU EXTENSION 1 FILED
Monday, September 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 1, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 29, 2021ASSIGNED TO LIE
Tuesday, December 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 28, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, December 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 28, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, December 28, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, December 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 20, 2021NON-FINAL ACTION E-MAILED
Monday, December 20, 2021NON-FINAL ACTION WRITTEN
Thursday, December 16, 2021ASSIGNED TO EXAMINER
Thursday, September 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 30, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 26, 2021NEW APPLICATION ENTERED

Related Keywords

forge cell preparations pharmaceutical including therapy immunotherapy tumors namely treatment cancer